Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.80 (+1.14%) Hang Seng
18,079.61 -150.59 (-0.83%) FTSE 100
8,282.01 +50.96 (+0.62%) Bitcoin USD
68,755.88 +669.20 (+0.98%) CMC Crypto 200
1,442.76 +14.19 (+0.99%)
Twist Bioscience Corporation (TWST)
After hours:
| Previous close | 40.69 |
| Open | 41.14 |
| Bid | 40.77 x 200 |
| Ask | 40.89 x 200 |
| Day's range | 40.04 - 41.34 |
| 52-week range | 14.42 - 50.50 |
| Volume | |
| Avg. volume | 945,069 |
| Market cap | 2.377B |
| Beta (5Y monthly) | 1.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.36 |
| Earnings date | 02 Aug 2024 - 06 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 43.76 |
Business WireTwist Bioscience to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., May 23, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its executives will present and participate in fireside chats at the following upcoming investor conferences:
ZacksWhat Makes Twist Bioscience (TWST) a Strong Momentum Stock: Buy Now?
Does Twist Bioscience (TWST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Business WireTwist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
SOUTH SAN FRANCISCO, Calif., May 13, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of Twist Multiplexed Gene Fragments (MGFs), pools of directly synthesized double-stranded DNA (dsDNA) up to 500 base pairs in length with no limit on sequence number to enable high throughput screening applications.
